Eli Lilly’s stock soars as successful trial of weight-loss pill is a game changer
If approved, the pill is expected to be far easier to administer than current injectables—and far easier to manufacture
If approved, the pill is expected to be far easier to administer than current injectables—and far easier to manufacture
